Fanconi anemia (FA) is an autosomal recessive disease with diverse cli
nical symptoms including developmental anomalies, bone marrow failure
and early occurrence of malignancies'. In addition to spontaneous chro
mosome instability, FA cells exhibit cell cycle disturbances and hyper
sensitivity to crosslinking agents(1). Eight complementation groups (A
-H) have been distinguished(2), each group possibly representing a dis
tinct FA gene(3). The genes mutated in patients of complementation gro
ups A (FANCA; refs 4,5) and C (FANCC; ref. 6) have been identified, an
d FANCD has been mapped to chromosome band 3p22-26 (ref. 7). An additi
onal FA gene has recently been mapped to chromosome 9p (ref. 8). Here
we report the identification of the gene mutated in group G, FANCG, on
the basis of complementation of an FA-G cell line and the presence of
pathogenic mutations in four FA-C patients. We identified the gene as
human XRCC9, a gene which has been shown to complement the MMC-sensit
ive Chinese hamster mutant UV40, and is suspected to be involved in DN
A post-replication repair or cell cycle checkpoint control(9,10). The
gene is localized to chromosome band 9p13 (ref. 9), corresponding with
a known localization of an FA gene.